CIK: 1752461 - Address: C/O Acumen Pharmaceuticals, Inc., 1210-1220 Washington Street, Suite 210, Newton, MA 02465
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/7/26 21:30
1/5/26
ABOSAcumen Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagMeisner Derek MMAOGC,Corp S.m-531.980-27-17134D
1/23/25 17:16
1/21/25
ABOSAcumen Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagMeisner Derek MMAOGC,Corp S-51.590-3-2161D
1/7/25 19:57
1/3/25
ABOSAcumen Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagMeisner Derek MMAOGC,Corp S.d-211.840-11-6165D
1/19/24 19:06
1/19/24
ABOSAcumen Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagMeisner Derek MVAOGC,Corp S-313.480-9-8109D
8/19/22 13:08
8/17/22
XFORX4 Pharmaceuticals, IncDEHealthBioPrdBiological Products, (No DiagMeisner Derek MMAOGCS00.000-8-5145D
6/27/22 16:08
6/24/22
XFORX4 Pharmaceuticals, IncDEHealthBioPrdBiological Products, (No DiagMeisner Derek MMAOGCS00.000-4-3153D
6/17/22 16:21
6/16/22
XFORX4 Pharmaceuticals, IncDEHealthBioPrdBiological Products, (No DiagMeisner Derek MMAOGCS00.000-4-3158D
8/19/21 16:26
8/17/21
XFORX4 Pharmaceuticals, IncDEHealthBioPrdBiological Products, (No DiagMeisner Derek MMAOGCS-425.100-8-1073D
6/25/21 16:03
6/24/21
XFORX4 Pharmaceuticals, IncDEHealthBioPrdBiological Products, (No DiagMeisner Derek MMAOGCS-297.000-4-581D
6/17/21 17:13
6/15/21
XFORX4 Pharmaceuticals, IncDEHealthBioPrdBiological Products, (No DiagMeisner Derek MMAOGCS-337.840-4-573D
9/10/20 08:31
9/9/20
XFORX4 Pharmaceuticals, IncDEHealthBioPrdBiological Products, (No DiagMeisner Derek MMAOGCS-678.050-8-3317D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact